Medical/Pharmaceuticals
Biocon Malaysia Recognised Across Five Categories at MOPI Pharma Industry Awards 2026
JOHOR BAHRU, Malaysia, Nov. 4, 2026 /PRNewswire/ -- Biocon Sdn. Bhd., Malaysia (Biocon Malaysia),a stepdown subsidiary of global biopharmaceuticals company Biocon Limited, has been recognised across five categories at the second edition of Malaysian Organisation of Pharmaceutical Industries' (MOP...
2026-11-04 11:15
Zuellig Pharma Strengthens Clinical Sourcing Capabilities in China through Strategic Acquisition
The acquisition of our newly licensed Hangzhou facility establishes robust local sourcing capabilities to accelerate and support clinical trials across China HANGZHOU, China, Nov. 4, 2026 /PRNewswire/ -- Zuellig Pharma, a leading healthcare solutions company in Asia, announced the strategic acqu...
2026-11-04 07:00
1115
LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization
* LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers clinical outcomes comparable to guidance by pressure wire-based FFR. * Conclusive trial results provide further randomized clinical evidence validat...
2026-11-03 19:05
2226
SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Late-breaking data presented at TCT 2026
2026-11-03 18:39
2081
Farrer Park Hospital Introduces The Edge® Multi-Port Endoscopic Surgical Robot, Expanding Patient Choice in Robotic Surgery in Singapore
SINGAPORE, Nov. 3, 2026 /PRNewswire/ -- Farrer Park Hospital (FPH) today announced the introduction of the Edge® Multi-Port Endoscopic Surgical Robot (MP1000) in Singapore. As FPH celebrates its 10th year, this milestone reflects its focus and commitment to value-based care by making advanced sur...
2026-11-03 11:00
3456
Laboratoires Pierre Fabre announces the approval of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer with a BRAFV600E mutation in Singapore
* New targeted treatment option now available in for adult patients with BRAF V600E mutant advanced non-small cell lung cancer (NSCLC) * Launch follows European approval based on results from the Phase II PHAROS trial, demonstrating meaningful clinical benefit to patients with a high objective...
2026-11-03 10:00
3704
ICP DAS-BMP to Showcase Medical TPU Innovations at COMPAMED 2026
HSINCHU, Nov. 3, 2026 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), will exhibit atCOMPAMED 2026, November 16–19 at Messe Düsseldorf, Germany (Hall 8b, Booth C09). The company will showcase its TPU p...
2026-11-03 09:15
2445
Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial
Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease TAMPA, Florida, Nov. 2, 2026 /PRNewswire/ -- Sirolimus-coated balloon (SCB) strategy was non-inferior to con...
2026-11-02 21:22
1995
OncoC4 Appoints Dr. Dan Janiak as Chief Business Officer
ROCKVILLE, Md., Nov. 2, 2026 /PRNewswire/ -- OncoC4, Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and immunological diseases, today announced the appointment of Dr. Dan Janiak as Chief Business Officer. Dan brings more than 15 years of experience bu...
2026-11-02 20:00
1614
Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune Reprogramming Research Accepted for Poster Presentation at 2026 San Antonio Breast Cancer Symposium
Presentations to Explore Paxalisib's Differentiated Tumor and Immune
Reprogramming Activity
SYDNEY, Nov. 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited
2026-11-02 20:00
2003
Lynk Pharmaceuticals Announces Commercialization Collaboration with Simcere for Zemprocitinib in Dermatology Indications, Further Expanding Product Commercialization Footprint
HANGZHOU, China, SHANGHAI and BOSTON, Nov. 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), today announced that it has expanded its commercialization collaboration with Simcere Pharmaceutical Group Limited ("Simcere") for zemprocitinib, a highly selective, oral, ...
2026-11-02 17:00
2623
Ascletis to Present Study Results of Oral Small Molecule GIPR Agonist ASC48 and GLP-1R/GIPR/GCGR Triple Peptide Agonist ASC37 at ObesityWeek® 2026
- Poster presentations feature preclinical in vitro and in vivo data of potentially first-in-class oral small molecule GIPR agonist ASC48 and next-generation once-monthly to once-quarterly GLP-1R/GIPR/GCGR triple peptide agonist ASC37 HONG KONG, Nov. 2, 2026 /PRNewswire/ -- Ascletis Pharma Inc. ...
2026-11-02 16:50
2420
Bracco Convenes Global CEUS Steering Committee to Strengthen International Collaboration and Help Shape the Future of Contrast-Enhanced Ultrasound
Second edition of the global CEUS Steering Committee brings together multidisciplinary experts to exchange scientific perspectives, identify emerging clinical and research opportunities and inform future evidence generations. LOMBARDY, Italy, Nov. 2, 2026 /PRNewswire/ -- Bracco convened the seco...
2026-11-02 16:00
1864
Self-Care Momentum Builds Across Asia-Pacific: Regional collaboration drives progress across health literacy, Regulatory streamlining and Leveraging Digital Solutions
BALI, Indonesia, Nov. 2, 2026 /PRNewswire/ -- Self-care is gaining momentum across Asia-Pacific, with more than 140 self-care initiatives aligned with the 2024 Bangkok Joint Initiative reported across the region in 2025 and 2026. Spanning health literacy, digital solutions, collaboration and stro...
2026-11-02 15:10
1938
Orthocell Achieves Strongest Month of U.S. Remplir™ Sales Since Launch
* Remplir™ is a collagen nerve wrap designed to support the repair and
protection of peripheral nerves. Designed and manufactured byOrthocell Ltd
2026-11-02 08:08
2651
Nuance Pharma Announces First Patient Dosed in REACH Phase III Trial of STG320 (Actair®) in China
SHANGHAI, Oct. 30, 2026 /PRNewswire/ -- Nuance Pharma announced that the first patient has been dosed in the REACH Phase III clinical trial evaluating STG320 (Actair®) for the treatment of house dust mite-induced allergic rhinitis in China. Stallergenes Greer's Actair® is a sublingual tablet cur...
2026-10-30 19:14
3501
Cambrex Breaks Ground on $120 Million Expansion in Charles City, Iowa
EAST RUTHERFORD, N.J., Oct. 30, 2026 /PRNewswire/ -- Cambrex, a leading global
contract development and manufacturing organization (CDMO), today marked the
groundbreaking of its $120 million expansion at its Charles City, Iowa facility.
2026-10-30 18:00
3138
KPJ Healthcare Sets Southeast Asian Record in Robotic Cardiac Surgery
Damansara Specialist Hospital 2 achieves regional first with 35 robotic-assisted minimally invasive cardiac surgery cases in 90 days KUALA LUMPUR, Malaysia, Oct. 30, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") has set a Southeast Asian record in robotic-assisted ...
2026-10-30 14:41
3374
Haier Biomedical Brings Blood Management and Pharmaceutical Cold Storage Expertise to AABB and ISPE 2026
ATLANTA and NATIONAL HARBOR, Md., Oct. 29, 2026 /PRNewswire/ -- Haier Biomedical
2026-10-29 21:50
4945
OncoC4 Announces Oral Presentation of a Late-Breaking Abstract on Cesalatamig at the 41st Annual Meeting of SITC
— Global Phase 1/2 Study Data in PD-(L)1–Resistant/Refractory NSCLC to Be Presented on November 7, 2026 — — Clinical Oral Abstract Session 2 Begins at 1:45 PM MST — ROCKVILLE, Md., Oct. 29, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical-stage biopharmaceutical company developing novel medicin...
2026-10-29 21:30
5770
Week's Top Stories
Most Reposted
Hong Leong Bank Strengthens Cross-Border Payment Connectivity through Partnership with UnionPay International
[Picked up by 294 media titles]
2026-10-28 12:12
Agoda becomes first travel platform regionally to seamlessly connect with Meta's Muse
[Picked up by 294 media titles]
2026-10-28 09:00
Klook launches K.ai, an AI agent that manages merchants' back-office operations
[Picked up by 293 media titles]
2026-11-03 14:31
Arrowpoint Investment Partners Selects Arcesium to Scale Asia-Focused Multi-Strategy Platform
[Picked up by 280 media titles]
2026-11-03 09:00OneQode Signs 14 MW AI Capacity Agreement with AdaniConneX, with a Path to 114 MW
[Picked up by 277 media titles]
2026-10-28 09:00
Most Read
1B views since June: Coda and TikTok Gaming turn content into commerce
2026-11-02 09:35
55287
iQIYI Launches China's First AI Film Studio in Shanghai, with Inaugural Title "Cop in Trouble" in Production
2026-11-02 09:52
48293
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
33068
